Xanthine oxidase from human liver: Purification and characterization

https://doi.org/10.1016/0003-9861(86)90539-4Get rights and content

Abstract

Xanthine oxidase [EC 1.2.3.2] was purified 2000-fold from human liver. The last step of the procedure involved affinity chromatography. The resulting preparation showed two closely migrating bands of enzyme activity after gel electrophoresis under nondenaturing conditions. No other proteins were detected on these gels. The average particle mass of the enzyme was 300 kDa as determined by size-exclusion chromatography. This together with results of gel electrophoresis under denaturing conditions suggested that the native enzyme was composed of two subunits of approximately 150 kDa each. The electrophoretic patterns also indicated that a portion of these subunits had undergone partial proteolysis. The substrate specificity of the purified human enzyme was studied using an assay in which phenazine ethosulfate coupled the transfer of electrons from the reduced enzyme to cytochrome c. Hypoxanthine, 2-hydroxypurine, xanthine, 2-aminopurine, and adenine were among the most efficient purine substrates studied. Most purine nucleosides tested were oxidized at detectable rates, but with relatively high Km values. The 2′-deoxyribonucleosides were more efficient substrates than were the corresponding ribonucleosides or arabinonucleosides. In a direct comparison with xanthine oxidase from bovine milk, the human enzyme showed a similar specificity toward purine substrates. However, considerable differences between the bovine and human enzymes were observed with nucleoside substrates. With xanthine as the substrate for the human enzyme, 20% of the total electron flow was univalently transferred to oxygen to produce superoxide radicals.

References (39)

  • T.A. Krenitsky et al.

    Arch. Biochem. Biophys

    (1972)
  • R.C. Bray
  • T.A. Krenitsky et al.

    Comp. Biochem. Physiol

    (1974)
  • T.A. Krenitsky

    Biochem. Pharmacol

    (1978)
  • T.A. Krenitsky et al.

    J. Biol. Chem

    (1976)
  • G.W. Koszalka et al.

    J. Biol. Chem

    (1979)
  • T. Spector et al.

    Anal. Biochem

    (1981)
  • L.G. Nagler et al.

    Biochim. Biophys. Acta

    (1976)
  • P.A. Furman et al.

    J. Biol. Chem

    (1984)
  • T. Nishino et al.

    FEBS Lett

    (1981)
  • E. Della Corte et al.

    Biochim. Biophys. Acta

    (1969)
  • F. Stirpe et al.

    J. Biol. Chem

    (1969)
  • W.R. Waud et al.

    Arch. Biochem. Biophys

    (1976)
  • W.R. Waud et al.

    Arch. Biochem. Biophys

    (1976)
  • T.A. Krenitsky et al.

    Arch. Biochem. Biophys

    (1978)
  • T.C. Laurent et al.

    J. Chromatogr

    (1964)
  • T. Spector et al.

    Biochem. Biophys. Res. Commun

    (1968)
  • R. Ghosh et al.

    Anal. Biochem

    (1979)
  • J.S. Olson et al.

    J. Biol. Chem

    (1974)
  • Cited by (119)

    • Human xanthine oxidase recombinant in E. coli: A whole cell catalyst for preparative drug metabolite synthesis

      2016, Journal of Biotechnology
      Citation Excerpt :

      Krenitsky et al. (1986) believed that even poor substrates for XOR would be completely metabolized by this enzyme, considering its relatively high abundance in the human body. XOR has been described to oxidize several types of substrates, from pyridines, pyrazines, purines, pyrimidines, quinolones to pterines (Krenitsky et al., 1986). It can also oxidize drugs such as 6-deoxyacyclovir (Krenitsky et al., 1984), 6-mercaptopurine (Bergmann and Ungar, 1960), famciclovir (Kitamura et al., 2006), allopurinol (Kitamura et al., 2006; Pacher et al., 2006), pyrazinamide (Yamamoto et al., 1987), 5-fluorouracil (Kitamura et al., 2006), and quinazoline (McCormack et al., 1978).

    • A continuous spectrophotometric enzyme-coupled assay for deoxynucleoside triphosphate triphosphohydrolases

      2016, Analytical Biochemistry
      Citation Excerpt :

      First, when considering that PNPase does not significantly discriminate between ribo- and deoxynucleosides [32], it is conceivable to assay ribonucleoside phosphohydrolases [33] such as apyrase (EC 3.6.1.5) [34]. Moreover, considering that Homo sapiens XOD is active toward adenine [35], the activity of enzymes releasing deoxyadenosine or adenosine could be assayed using the procedure described here. Therefore, it is our hope that the commercial repertoire of XODs from different sources will be expanded, giving the opportunity to widen the applications of the enzyme-coupled assay described here.

    • Xanthine oxidase inhibitory properties and anti-inflammatory activity of 2-amino-5-alkylidene-thiazol-4-ones

      2015, Chemico-Biological Interactions
      Citation Excerpt :

      Xanthine oxidase (XO) is a highly versatile flavoprotein enzyme, ubiquitous among species (from bacteria to human) and within the various tissues of mammals [1]. It catalyzes the last two steps in the purine degradation pathway prior to formation of uric acid, that is, hydroxylation of hypoxanthine to xanthine, and then to uric acid [2]. There is an overwhelming acceptance that XO serum levels are significantly increased in various pathological states like hepatitis, inflammation, ischemia–reperfusion, carcinogenesis and aging, and that ROS generated in the enzymatic process are involved in oxidative damage.

    View all citing articles on Scopus
    View full text